Acth and Slow rhr - a phase IV clinical study of FDA data

Summary:

Slow rhr is reported as a side effect among people who take Acth (corticotropin), especially for people who are male, 0-1 old, have been taking the drug for < 1 month also take Keppra, and have Infantile spasms.

The phase IV clinical study analyzes which people have Slow rhr when taking Acth. It is created by eHealthMe based on reports of 5,384 people who have side effects when taking Acth from the FDA, and is updated regularly.

What is Acth?

Acth has active ingredients of corticotropin. eHealthMe is studying from 5,402 Acth users. Check the latest studies of Acth.

What is Slow rhr?

Slow rhr is found to be associated with 2,916 drugs and 3,008 conditions by eHealthMe. Check the latest studies of Slow rhr.

On May, 22, 2026

5,384 people reported to have side effects when taking Acth.
Among them, 19 people (0.35%) have Slow rhr.

Among these 19 people:

How long have people been on Acth when they have Slow rhr? *

What is the gender of people who have Slow rhr when taking Acth? *

female: 41.18 %
male: 58.82 %

What is the age of people who have Slow rhr when taking Acth? *

What are other drugs people take besides Acth? *

Keppra: 2 people, 10.53%
Vigabatrin: 1 person, 5.26%
Tpn: 1 person, 5.26%
Synthroid: 1 person, 5.26%
Synagis: 1 person, 5.26%
Pepcid: 1 person, 5.26%
Lasix: 1 person, 5.26%
Imodium: 1 person, 5.26%
Flovent Hfa: 1 person, 5.26%
Clonidine Hydrochloride: 1 person, 5.26%

What are other side effects people have besides Slow rhr? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 15.79%
High Blood Pressure: 3 people, 15.79%
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions): 2 people, 10.53%
Movement - Unpredictable Or Jerky: 2 people, 10.53%
Autonomic Nervous System Imbalance (autonomic nervous system is of net equal emphasis): 2 people, 10.53%
Tachypnea: 2 people, 10.53%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 10.53%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 10.53%
Infantile Spasms: 2 people, 10.53%
Drowsiness: 2 people, 10.53%

What are the existing conditions these people have? *

Infantile Spasms: 18 people, 94.74%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.26%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.26%
Chronic Renal Failure (kidney failure): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Acth and have Slow rhr?

- Check whether Slow rhr is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acth:

Acth (5,402 reports)

Slow rhr treatments and more:

Slow rhr (61,180 reports)

Browse all side effects of Acth:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Slow rhr:

Slow rhr (2,916 drugs)

Browse all the conditions that are associated with Slow rhr:

Slow rhr (3,008 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on corticotropin (the active ingredients of Acth) and Acth (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.